Approval times for supplemental indications for recombinant proteins
This new study shows that, in the US, approval of supplemental indications for recombinant protein products takes an average of seven months longer than approval of the original indication.
Gespeichert in:
Veröffentlicht in: | Bio/technology (New York, N.Y. 1983) N.Y. 1983), 1997-02, Vol.15 (2), p.130-134 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This new study shows that, in the US, approval of supplemental indications for recombinant protein products takes an average of seven months longer than approval of the original indication. |
---|---|
ISSN: | 0733-222X |